CINCINNATI, July 27 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL - News), a leading, global full-service clinical research organization, today appointed Stephen Cutler, PhD, as the Company’s new Senior Vice President and Chief Operating Officer (COO) effective immediately. Dr. Cutler brings to Kendle more than 20 years of senior management and operations leadership experience in the CRO and biopharmaceutical industries to position the Company for continued growth as a top-tier global CRO. Dr. Cutler will provide global leadership for the Company’s worldwide Late Stage operations, leveraging its combined capabilities across Phase II-IV to maximize delivery of integrated service offerings for customers. He assumes the COO role from Chris Bergen who has been appointed Executive Vice President and Chief Administrative Officer (CAO). Dr. Cutler will report directly to Chairman and CEO Candace Kendle, PharmD.
